Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This target group represents a complex network of cell surface receptors expressed on tenocytes, mesenchymal stem cells (MSCs), and related musculoskeletal cells that collectively regulate tissue homeostasis and repair. Key receptors include the TGF-beta and BMP receptor families, which are essential for tenogenic differentiation and the expression of the transcription factor Scleraxis (Docheva et al., 2015, PubMed). Additionally, receptor tyrosine kinases such as IGF-1R, FGFR, and PDGFR mediate the proliferative and anabolic effects of growth factors often found in orthobiologic preparations like platelet-rich plasma (Molloy et al., 2003, PubMed). Chemokine receptors like CXCR4 are also critical for the homing of MSCs to injured musculoskeletal tissues (Dominici et al., 2006, PubMed). In clinical applications, these receptors are targeted to accelerate healing in tendinopathies and ligamentous injuries by stimulating the synthesis of Type I collagen and other extracellular matrix components. However, because these receptors participate in overlapping and sometimes antagonistic signaling pathways, therapeutic intervention requires careful balance to avoid pathological outcomes. For instance, overactivation of TGF-beta signaling can lead to excessive fibrosis, while BMP signaling may inadvertently trigger ectopic bone formation within soft tissues. Understanding the spatial and temporal expression of these receptors is vital for developing targeted regenerative therapies in sports medicine and orthopedics.
Activation of diverse intracellular signaling cascades, including the SMAD, MAPK/ERK, and PI3K/Akt pathways, to stimulate tenogenic gene expression (e.g., Scleraxis), promote collagen production, and facilitate the recruitment and differentiation of mesenchymal stem cells to the site of injury.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Musculoskeletal growth factor, cytokine, and chemokine receptors.